Search results
Author(s):
Jonathan Byrne
,
Mamta Buch
,
Michael Mullen
,
et al
Added:
3 months ago
Author(s):
Mark Ricciardi
Added:
9 months ago
HFSA Congress 2024 - Dr Mark Ricciardi (NorthShore Cardiovascular Institute, US) joins us to discuss the findings from the EXPANDed real-world clinical trial on mitral transcatheter edge-to-edge repair with the MitraClip System.The study is designed to confirm the safety and performance of the MitraClip NTR and XTR Systems in mTEER procedures. 1000 patients across 60 sites in Europe and the US…
View more
Transcatheter Therapies for FMR
Author(s):
Stephanie K Tom
,
Kanika Kalra
,
Emily Perdoncin
,
et al
Added:
1 year ago
Article
Author(s):
Jelena Z Arnautovic
,
Lina Ya’Qoub
,
Zarghoona Wajid
,
et al
Added:
8 months ago
Author(s):
Tomohiro Kaneko
Added:
1 month ago
EuroPCR 25 - Real-world registry findings show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR).We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from two large-scale Japanese registries,…
View more
Author(s):
Lucas Uchoa de Assis
,
Giulio M Mondellini
,
Mark MP van den Dorpel
,
et al
Added:
4 months ago
Author(s):
Firas Zahr
Added:
8 months ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP…
View more
Author(s):
Stephan Baldus
Added:
8 months ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,…
View more
Author(s):
,
Start date:
Aug 06, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday…
View more
Author(s):
Robert Cubeddu, MD
,
Dee Dee Wang
,
Viviana Navas, MD
Added:
10 months ago
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Explore case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients.
View more